Immune Checkpoint Inhibitor-Based Combination Therapy for Colorectal Cancer: An Overview
Jingjing Li, Xuanfu Xu Department of Gastroenterology, Shidong Hospital of Shanghai, Shanghai, People’s Republic of ChinaCorrespondence: Xuanfu Xu, Department of Gastroenterology, Shidong Hospital of Shanghai, Shanghai, People’s Republic of China, Tel +86-021-25066666, Email shuanfusky@163.comAbstra...
Main Authors: | Li J, Xu X |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2023-04-01
|
Series: | International Journal of General Medicine |
Subjects: | |
Online Access: | https://www.dovepress.com/immune-checkpoint-inhibitor-based-combination-therapy-for-colorectal-c-peer-reviewed-fulltext-article-IJGM |
Similar Items
-
Is There a Place for Immunotherapy for Metastatic Microsatellite Stable Colorectal Cancer?
by: François Ghiringhelli, et al.
Published: (2019-08-01) -
Overview of the Cardiotoxicity Induced by PD-1/PD-L1 Immune Checkpoint Inhibitor in Critical Care
by: Ruiting Li, et al.
Published: (2021-06-01) -
PD-L1 positive platelets mediate resistance to immune checkpoint inhibitors in patients with colorectal cancer
by: Jiacheng Li, et al.
Published: (2025-01-01) -
An overview of immune checkpoint inhibitor toxicities in bladder cancer
by: Avenie Mavadia, et al.
Published: (2024-12-01) -
Immune Checkpoint Inhibitors in Cancer Therapy
by: Yavar Shiravand, et al.
Published: (2022-04-01)